Drs. Jesús Berdeja, Director of Multiple Myeloma Research at Tennessee Oncology and Joanna Rhodes, Director of Lymphoma Program at Rutgers Cancer Institute of New Jersey invite you to join them at the inaugural 2-day CE accredited conference Nashville Hematology Conference in Tennessee.
Discuss optimal evidence-based management of patients with hematologic malignancies across treatment settings.
Share best practices in incorporating T-cell redirecting therapies into practice with particular focus on managing acute and long-term potential toxicities.
Apply current prognostic testing to everyday practice across hematologic malignancies and throughout the patient journey.
Recognize challenges of treating hematologic malignancies in patients with unmet needs in the community setting including frail patients and disparate populations.
For more information on sponsorship opportunities, please submit this form: